A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
NCT06667908
This study is recruiting at 17 US sites in 14 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can improve objective response rate (ORR; that is percentage of participants whose best response is complete response or partial response during the study) in participants with locally advanced and unresectable stage III non-small cell lung cancer.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Carcinoma, Non-Small-Cell Lung
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Johnson & Johnson Enterprise Innovation Inc.
- Last updated on ClinicalTrials.gov
- September 25, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Moores Cancer Center at UC San Diego Health · La Jolla, CA
Connecticut · 1
- Yale University · New Haven, CT
Florida · 2
- University of Miami · Miami, FL
- Orlando Health Cancer Institute · Orlando, FL
Georgia · 1
- Emory University Winship Cancer Institute · Atlanta, GA
Massachusetts · 1
- Beth Israel Deaconess Medical Center · Boston, MA
Missouri · 1
- Washington University in St Louis · St Louis, MO
New Jersey · 1
- Rutgers Cancer Institute of New Jersey · New Brunswick, NJ
New York · 2
- Memorial Sloan Kettering Cancer Center · New York, NY
- NYU Langone Health · New York, NY
North Carolina · 2
- University of North Carolina at Chapel Hill · Chapel Hill, NC
- FirstHealth of the Carolinas · Pinehurst, NC
Ohio · 1
- University Hospitals Cleveland Medical Center · Cleveland, OH
Oregon · 1
- Oregon Health And Science University · Portland, OR
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Texas · 1
- MD Anderson Cancer Center · Houston, TX
Vermont · 1
- University of Vermont Medical Center · Burlington, VT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.